| Vaccination coverage rates in eleven European countries during two consecutive influenza seasons PR Blank, M Schwenkglenks, TD Szucs Journal of Infection 58 (6), 446-458, 2009 | 327 | 2009 |
| Influenza vaccination uptake and socioeconomic determinants in 11 European countries MM Endrich, PR Blank, TD Szucs Vaccine 27 (30), 4018-4024, 2009 | 242 | 2009 |
| Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons PR Blank, M Schwenkglenks, TD Szucs BMC public health 8, 1-11, 2008 | 230 | 2008 |
| Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons PR Blank, M Schwenkglenks, TD Szucs Infection 37, 390-400, 2009 | 106 | 2009 |
| Reconstruction versus conservative treatment after rupture of the anterior cruciate ligament: cost effectiveness analysis M Farshad, C Gerber, DC Meyer, A Schwab, PR Blank, T Szucs BMC health services research 11, 1-9, 2011 | 93 | 2011 |
| KRAS and BRAF Mutation Analysis in Metastatic Colorectal Cancer: A Cost-effectiveness Analysis from a Swiss Perspective PR Blank, H Moch, TD Szucs, M Schwenkglenks Clinical Cancer Research 17 (19), 6338-6346, 2011 | 82 | 2011 |
| The scientific basis for offering seasonal influenza immunisation to risk groups in Europe A Nicoll, BC Ciancio, S Tsolova, PR Blank, C Yilmaz Eurosurveillance 13 (43), 2008 | 78 | 2008 |
| Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR‐HF trial: an analysis for the UK FS Gutzwiller, M Schwenkglenks, PR Blank, PG Braunhofer, C Mori, ... European journal of heart failure 14 (7), 782-790, 2012 | 68 | 2012 |
| The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly P Blank, M Schwenkglenks, TD Szucs Human Vaccines & Immunotherapeutics 8 (3), 328-335, 2012 | 67 | 2012 |
| Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006 MV Holm, PR Blank, TD Szucs BMC infectious diseases 7, 1-8, 2007 | 59 | 2007 |
| Personalized cancer medicine and the future of pathology H Moch, PR Blank, M Dietel, G Elmberger, KM Kerr, J Palacios, ... Virchows Archiv 460, 3-8, 2012 | 57 | 2012 |
| Increasing influenza vaccination coverage in recommended population groups in Europe PR Blank, TD Szucs Expert review of vaccines 8 (4), 425-433, 2009 | 54 | 2009 |
| Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost–effectiveness analysis of different predictive assay strategies PR Blank, M Schwenkglenks, H Moch, TD Szucs Breast cancer research and treatment 124, 497-507, 2010 | 42 | 2010 |
| Attitudes of the general public and general practitioners in five countries towards pandemic and seasonal influenza vaccines during season 2009/2010 PR Blank, G Bonnelye, A Ducastel, TD Szucs Public Library of Science 7 (10), e45450, 2012 | 40 | 2012 |
| sFlt-1/PlGF ratio as a predictive marker in women with suspected preeclampsia: an economic evaluation from a Swiss perspective M Hodel, PR Blank, P Marty, O Lapaire Disease markers 2019, 2019 | 39 | 2019 |
| Vaccination and healthy ageing: how to make life-course vaccination a successful public health strategy JP Michel, M Gusmano, PR Blank, I Philp European Geriatric Medicine 1 (3), 155-165, 2010 | 36 | 2010 |
| Influenza vaccination: key facts for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and … G Kassianos, P Blank, O Falup-Pecurariu, E Kuchar, J Kyncl, ... Drugs in context 5, 2016 | 35 | 2016 |
| Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland PR Blank, TD Szucs Vaccine 30 (28), 4267-4275, 2012 | 32 | 2012 |
| Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa LL Widmer, PR Blank, K Van Herck, C Hatz, P Schlagenhauf BMC infectious diseases 10, 1-10, 2010 | 30 | 2010 |
| Stroke in Switzerland: social determinants of treatment access and cost of illness P Snozzi, PR Blank, TD Szucs Journal of Stroke and Cerebrovascular Diseases 23 (5), 926-932, 2014 | 29 | 2014 |
